---
$id: https://graph.org.ai/products/commodity/51162732
$type: Product
source: UNSPSC
code: "51162732"
title: "Oxymetazoline"
class: "51162700"
classTitle: "Decongestants, expectorants, and mucolytics"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Oxymetazoline

**UNSPSC Code**: 51162732
**Class**: [Decongestants, expectorants, and mucolytics](Decongestants, expectorants, and mucolytics.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an alpha-adrenergic agonist with the molecular formula C16H24N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 8VLN5B44ZY, chemically known as 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol but more generally known as oxymetazoline, which bears US NIH Compound Identifier 4636. European Medicines Agency schedules Oxymetazoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09567MIG. The term OXYMETAZOLINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). World Health Organization schedules oxymetazoline in its Anatomical Therapeutic Chemical (ATC) Classification. OXYMETAZOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule oxymetazoline under HS 29332990 and SITC 51573. As of Q4 2014, OXYMETAZOLINE remains US FDA's Preferred Term for this commodity. Oxymetazoline bears US NLM identifiers UMLS ID C0030071 and NCI Concept Code C61871. SMILES: OC1C(C(C)(C)C)CC(C(C1C)CC1=NCCN1)C.

